A ureteral stent is a thin tube that is inserted into the ureter to prevent or treat renal urine flow obstruction. This procedure is used to restore urine flow via obstructed ureters while maintaining kidney function. These devices are used to treat kidney stones, tumors, and urine incontinence during or after treatment. Vesicoureteral problems, stenosis, and occlusion of the ureter tube are common after kidney donation. As a result, ureteral stents are utilized to reduce the number of issues related with kidney transplantation, such as urine leakage, ureteric stenosis, and obstruction. For example, a double-J ureteral stent successfully cures mild ureteric leaks and transplant ureter blockage.
The major factors that drive the growth of the ureteral stents market include, increase in the incidence of urological diseases caused by colonization of microorganisms or sedentary lifestyle. In addition, rise in number of kidney transplants, surge in geriatric population, and technological advancements in stents composition materials are expected to boost the market growth. However, lack of skilled professionals and adverse effects associated with the use of ureteral stents impede the market growth.
The ureteral stents market is segmented on the basis of product type, application, materials, end users, and region. According to product type, the market is divided into open end stents, double pigtail stents, closed end stents, and multiloop stents. According to materials, the market is divided into metallic stents and polymer stents. On the basis of application, the market is divided into kidney stones, tumors, urinary incontinence, kidney transplantation, and others. On the basis of end users, the market is divided into hospitals, clinics, and ambulatory surgical centers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include, Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Inc., Coloplast Ltd., Medline Industries, Inc., Allium Medical Solutions Ltd., Pnn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
The major factors that drive the growth of the ureteral stents market include, increase in the incidence of urological diseases caused by colonization of microorganisms or sedentary lifestyle. In addition, rise in number of kidney transplants, surge in geriatric population, and technological advancements in stents composition materials are expected to boost the market growth. However, lack of skilled professionals and adverse effects associated with the use of ureteral stents impede the market growth.
The ureteral stents market is segmented on the basis of product type, application, materials, end users, and region. According to product type, the market is divided into open end stents, double pigtail stents, closed end stents, and multiloop stents. According to materials, the market is divided into metallic stents and polymer stents. On the basis of application, the market is divided into kidney stones, tumors, urinary incontinence, kidney transplantation, and others. On the basis of end users, the market is divided into hospitals, clinics, and ambulatory surgical centers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include, Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Inc., Coloplast Ltd., Medline Industries, Inc., Allium Medical Solutions Ltd., Pnn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ureteral stents market analysis from 2020 to 2030 to identify the prevailing ureteral stents market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ureteral stents market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global ureteral stents market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Open End Stents
- Closed End Stents
- Double Pigtail Stents
- Multiloop Stents
By Material
- Metallic Stents
- Polymer Stents
By Application
- Kidney Stones
- Kidney Transplantation
- Tumors
- Urinary Incontinence
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers (ASCs)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Allium Medical Solutions Ltd.
- BOSTON SCIENTIFIC CORPORATION
- B. BRAUN MELSUNGEN AG
- COOK MEDICAL, INC.
- COLOPLAST A/S
- C. R. BARD INC.
- MEDLINE INDUSTRIES, INC.
- OLYMPUS CORPORATION
- PNN MEDICAL A/S
- TELEFLEX INCORPORATED
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: URETERAL STENTS MARKET, BY PRODUCT TYPE
CHAPTER 5: URETERAL STENTS MARKET, BY MATERIAL
CHAPTER 6: URETERAL STENTS MARKET, BY APPLICATION
CHAPTER 7: URETERAL STENTS MARKET, BY END USER
CHAPTER 8: URETERAL STENTS MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Ureteral Stents Market,' the ureteral stents market was valued at $362.34 million in 2020, and is estimated to reach $625.17 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030.Ureteral stent is a thin hollow tube that is inserted into the ureter to alleviate blockages in the kidney's urine flow. These stents are used to treat various urological disorders, such as kidney stones, tumors, and urinary incontinence. These ureteral stents allow remaining fragments to pass through without blocking the ureter. In fact, any urological or kidney-related procedure mostly necessitates the use of a ureteral stent for the ureter to recover properly. The ureteral stent removal takes place after treatment procedure. Furthermore, the high prevalence of prostate cancer, tumors, or ureteral narrowing/scarring necessitates the use of ureteral stents during and after therapy.
Increase in number of kidney transplants, surge in geriatric population, and technological advancements in stents composition materials drive the Ureteral Stents Market growth. In addition, increase in the incidence of urological diseases caused by colonization of microorganisms or sedentary lifestyle is the major factor further boosts the market growth. However, lack of skilled professionals and adverse effects associated with the use of ureteral stents hinder the market growth.
On the basis of product type, the global ureteral stents market is categorized into open end stents, double pigtail stents, closed end stents, and multiloop stents. The double pigtail stents segment is expected to dominate the market during the forecast period, owing to increase in urological disorders and urological obstruction, high demand for stents with minimized migration, and rise in awareness about advanced stents with less complications. In addition, numerous initiatives taken by government and healthcare agencies also boost the market growth. The multiloop stents segment is expected to register a CAGR of 8.3% during the forecast period, due to advancement in stent technology, high demand for polymer materials, such as Percuflex, and development of stents with soft, smooth, and flexible surface biocompatible stents.
On the basis of application, the urinary incontinence segment accounted for a major share of the market share in the global ureteral stents market in 2020. This segment is expected to exhibit a prominent growth ureteral stents market trends, owing to increase in geriatric population. In addition, the employment of ureteral stent, mainly double-J stent, ensures an appropriate urinary drainage from the kidney to the bladder.
On the basis of material, the metallic stents segment accounted for a major share of the ureteral stents market size in the global ureteral stents market in 2020. This segment is expected to exhibit a prominent growth rate, owing to the resistance of metallic ureteral stents to encrustation with stone material. This provides longer dwelling time and reduces the frequency of stent change surgeries.
On the basis of end user, the ureteral stents industry is classified as hospitals, clinics, and ambulatory surgical centers. the hospitals segment accounted for more than 6.3% of the global market share in 2020, and is expected to remain dominant during the forecast period, as the placement of the stent requires anesthesia to prevent the pain caused during surgery, which is easily possible at hospitals. Furthermore, the increase in incidence of urological disorders owing to the rise in mean age of the population has resulted in rise in number of hospitalizations. In addition, hospitals provide multi-specialty or multi healing, and operate in efficient and cost-effective way.
North America accounted for more than 5.9% of the global ureteral stents market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to presence of well-established healthcare systems and increase in prevalence of diseases, such as kidney stones and tumors. In addition, higher adoption rate for technologically advanced devices also boosts the market growth. Asia-Pacific is projected to register the highest CAGR of 6.3% during the forecast period, owing to rise in healthcare expenditure, increase in per capita income, growth in demand for healthcare services from a large patient pool, and improvement in healthcare infrastructure.
The major companies profiled in the report include, Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Inc., Coloplast Ltd., Medline Industries, Inc., Allium Medical Solutions Ltd., Pnn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
Key findings of the Study
- By product type, the double pigtail stents segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 5.2% from 2021 to 2030.
- By application, the urinary incontinence segment is projected to grow at a CAGR of 4.9% during the forecast period.
- By material, the metallic stents segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 4.6% from 2021 to 2030.
- Region-wise, North America is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.
Companies Mentioned
- Allium Medical Solutions Ltd.
- BOSTON SCIENTIFIC CORPORATION
- B. BRAUN MELSUNGEN AG
- COOK MEDICAL, INC.
- COLOPLAST A/S
- C. R. BARD INC.
- MEDLINE INDUSTRIES, INC.
- OLYMPUS CORPORATION
- PNN MEDICAL A/S
- TELEFLEX INCORPORATED
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
